Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial polysaccharides, endotoxins, and immunomodulation.

P J Baker1, C E Taylor, F S Ekwunife

  • 1Laboratory of Immunogenetics, NIAID, National Institutes of Health, Rockville, Maryland 20852.

Advances in Experimental Medicine and Biology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of the Discriminating Concentration Towards Permethrin for Surveying Resistance in Amblyomma americanum.

Journal of medical entomology·2022
Same author

Hard two-body photodisintegration of 3He.

Physical review letters·2014
Same author

Assessment of human baroreflex function using carotid ultrasonography: what have we learnt?

Acta physiologica (Oxford, England)·2014
Same author

Genetic variation in irradiated and control populations of Cnemidophorus tigris (sauria, teiidae) from Mercury, Nevada with a discussion of genetic variability in lizards.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2014
Same author

Sarcoptic mange in vicuña (Vicugna vicugna) population in Peru.

The Veterinary record·2013
Same author

Postural influences on the mechanical and neural components of the cardiovagal baroreflex.

Acta physiologica (Oxford, England)·2013

Nontoxic monophosphoryl lipid A (MPL) can serve as a safe adjuvant by removing inhibitory T-cell activity. This enhances immune responses to antigens and holds promise for developing tumor immunity.

Area of Science:

  • Immunology
  • Adjuvant therapy
  • Vaccine development

Background:

  • Lipopolysaccharide (LPS) and its derivatives exhibit adjuvant effects by suppressing inhibitory T-cells (Ts).
  • A normal immune response involves the activation of Ts, which can limit overall immunogenicity.
  • Existing adjuvants like Freund's complete adjuvant have limitations.

Purpose of the Study:

  • To investigate the potential of nontoxic monophosphoryl lipid A (MPL) as a safe and effective adjuvant.
  • To determine if MPL can enhance the immunogenicity of poorly immunogenic antigens.
  • To evaluate MPL's impact on various T-cell functions, including helper (Th), activating (Ta), and cytotoxic (Tc) cells.

Main Methods:

  • Studies were conducted to assess the adjuvant effects of LPS derivatives.

Related Experiment Videos

  • The capacity of nontoxic MPL to modulate Ts activity was examined.
  • Comparative analysis of MPL's influence on different T-cell subsets was performed.

    • Main Results:

    • MPL effectively eliminates the inhibitory effects of Ts, similar to LPS but without toxicity.
    • MPL demonstrates potential as a safe alternative to Freund's complete adjuvant for boosting immune responses.
    • MPL selectively removes Ts activity without negatively affecting Th, Ta, and Tc cell functions.

    Conclusions:

    • Nontoxic MPL is a promising adjuvant that enhances immunogenicity by removing Ts-mediated inhibition.
    • MPL's ability to preserve other T-cell functions makes it a valuable tool for improving immune responses.
    • The findings suggest significant implications for the development of effective tumor immunity strategies.